| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 01/03/2007 | EP1658273B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 01/03/2007 | EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 01/03/2007 | CN1890236A Novel thiazole derivates |
| 01/03/2007 | CN1890228A Alpha-amino acid derivatives and use thereof as medicines |
| 01/03/2007 | CN1889947A Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 01/03/2007 | CN1889836A Insecticidal n-(heteroarylalkyl)alkanediamine derivatives |
| 01/03/2007 | CN1293070C Quinoline derivatives |
| 01/03/2007 | CN1293058C O-cyclopropyl-carboxanilides and their use as fungicides |
| 01/03/2007 | CN1293042C Aromatic amino acid derivates and medicinal compositions |
| 01/03/2007 | CN1293034C New gamma selective retinoids |
| 01/02/2007 | US7157595 In presence of alpha-olefin; ester hydrolysis |
| 01/02/2007 | US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions |
| 01/02/2007 | US7157490 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/02/2007 | US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders |
| 01/02/2007 | US7157480 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 01/02/2007 | US7157479 Oxazol/thiazol-derivatives activators of the hPPAR-alpha receptor |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases |
| 01/02/2007 | CA2400226C Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 12/28/2006 | WO2006137376A1 Amide derivative and pesticide containing such compound |
| 12/28/2006 | WO2006137258A1 Pharmaceutical composition comprising azarhodacyanine compound as active ingredient |
| 12/28/2006 | WO2006058648A3 Biaryloxymethylarene carboxylic acids |
| 12/28/2006 | WO2006020680A3 Heterocyclic compounds as pharmaceutical agents |
| 12/28/2006 | US20060293366 Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors |
| 12/28/2006 | US20060293365 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
| 12/28/2006 | US20060293338 protein serine/threonine kinase inhibitors such as 2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one, used for treating autoimmune diseases, HIV, cancer, anemia myelodysplastic syndrome and thrombocytopenia |
| 12/28/2006 | US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase |
| 12/28/2006 | US20060293286 Resistant-repellent retroviral protease inhibitors |
| 12/28/2006 | CA2612338A1 Sphingosine kinase inhibitors |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1735319A1 Inhibitors of histone deacetylase |
| 12/27/2006 | EP1735292A1 Thiazole-amine compounds for the treatment of neurodegenerative disorders |
| 12/27/2006 | EP1735291A2 Rosiglitazone phosphate and polymorphic forms |
| 12/27/2006 | EP1735280A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
| 12/27/2006 | EP1735275A2 Aryl sulfones and uses related thereto |
| 12/27/2006 | EP1735270A1 Diamino alcohols and their use as renin inhibitors |
| 12/27/2006 | EP1734957A2 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders |
| 12/27/2006 | EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 12/27/2006 | EP1654324B1 Sulphonamide anions as catalysts for nco oligomerisation |
| 12/27/2006 | EP1480961B1 Glutaminyl based dpiv inhibitors |
| 12/27/2006 | EP1358144B1 Epothilone synthesis components i: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone and epothilone derivatives |
| 12/27/2006 | EP1103560B1 Novel thiazolidine derivatives |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | CN1886421A Hemiasterlin derivatives and uses thereof |
| 12/27/2006 | CN1886386A Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 12/27/2006 | CN1291993C N-substituted benzothiazolyl-1-substituted phenyl-0,0-dialkyl-alpha-amino phosphonate ester derivatives, their preparation and application |
| 12/27/2006 | CN1291985C Neurotrophin production/secretion promoting agent |
| 12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |
| 12/27/2006 | CN1291981C Method for preparing 3-methyl-2-benzothiazolinone hydrazone and its hydrochloride |
| 12/26/2006 | US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics |
| 12/26/2006 | US7153882 (Aminocarbonyloxy)-benzofused ring derivatives; Alzheimer*s disease; neurodegenerative disorders |
| 12/26/2006 | US7153878 Substituted thiazoles and oxazoles, e.g., 4-{1-[4-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethylsulfanyl}-2-methyl-phenoxy)-acetic acid; treating atherosclerosis and diabetes and creating Syndrome X |
| 12/26/2006 | US7153875 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
| 12/26/2006 | US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer |
| 12/26/2006 | US7153815 Insecticide containing hydrazone derivative as the active ingredient and novel hydrazone derivative |
| 12/21/2006 | WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/21/2006 | WO2006089076A3 Thiazole amides, imidazole amides and related analogues |
| 12/21/2006 | WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 12/21/2006 | US20060287396 4-aryl quinols and analogs thereof as therapeutic agents |
| 12/21/2006 | US20060287374 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 12/21/2006 | US20060287373 Cathepsin cysteine protease inhibitors |
| 12/21/2006 | US20060287371 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R*,7S*,8R*,9R*,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents |
| 12/21/2006 | US20060287304 Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient |
| 12/21/2006 | US20060286065 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 12/21/2006 | CA2611480A1 (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one |
| 12/21/2006 | CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/20/2006 | EP1732906A1 2-aminothiazole compounds useful as aspartyl protease inhibitors |
| 12/20/2006 | EP1732905A1 2-aminomethylthiazole-5-carboxamides as protein kinase modulators |
| 12/20/2006 | EP1732895A2 Insecticidal n-substituted sulfoximines |
| 12/20/2006 | EP1732884A1 Sulphonamide derivatives |
| 12/20/2006 | EP1670458B1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
| 12/20/2006 | EP1188745B1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same |
| 12/20/2006 | EP1133485B1 A process for the synthesis of ritonavir |
| 12/20/2006 | CN1882560A Heterocompound and its production and usage method |
| 12/20/2006 | CN1882556A Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 12/20/2006 | CN1882555A 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents |
| 12/20/2006 | CN1882553A Phenylacetic acid derivative, process for producing the same, and use |
| 12/20/2006 | CN1880308A Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents |
| 12/20/2006 | CN1290500C Retroviral protease inhibitor combinations |
| 12/19/2006 | US7150958 Splitting using laser radiation |
| 12/14/2006 | WO2006133459A1 Indane derivatives as modulators of ion channels |
| 12/14/2006 | WO2006132442A1 Vitamin d-like compound |
| 12/14/2006 | WO2006131232A1 Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors |
| 12/14/2006 | US20060281926 Synthesis of 2-alkylcysteine via phase transfer catalysis |
| 12/14/2006 | US20060281798 Methods of using thiazolidinedithione derivatives |
| 12/14/2006 | US20060281736 Product comprising at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 12/14/2006 | US20060280746 (1E)-1-{[(3-amino-4-methoxyphenyl)methyl]sulfinyl}-2-(2,4,6-trimethoxyphenyl)ethene; antiproliferative agents; offers protection from the cytotoxic effects of ionizing radiation and of cytotoxic chemotherapeutic agents |
| 12/14/2006 | DE102005026809A1 Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen Benzothiazol-2-one derivatives as inhibitors of lipases, and phospholipases |
| 12/14/2006 | CA2611731A1 Indane derivatives as modulators of ion channels |
| 12/14/2006 | CA2609560A1 Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors |
| 12/13/2006 | EP1731514A1 Process for the preparation of Pramipexole |
| 12/13/2006 | EP1730129A2 Intermediates for the preparation of pramipexole |
| 12/13/2006 | EP1730128A1 Anaplastic lymphoma kinase modulators and methods of use |
| 12/13/2006 | EP1730100A1 Polyamine analogs that activate antizyme frameshifting |
| 12/13/2006 | EP1729774A1 Pyrrolidine compounds |
| 12/13/2006 | EP1729756A2 Novel pharmaceutical compositions |
| 12/13/2006 | EP1483241A4 Cyclic derivatives as modulators of chemokine receptor activity |
| 12/13/2006 | EP1385823B1 Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists |
| 12/13/2006 | EP1294823B1 Double-spiro organic compounds and electroluminescent devices |
| 12/13/2006 | CN1878779A 2'oxo-voruscharin and derivatives thereof |